Connect with us


Second Sight Completes Merger and Changes Its Name

The developer of implantable visual prosthetics combined with Nano Precision Medical.




Second Sight Medical Products Inc. has completed its merger with Nano Precision Medical Inc.

Second Sight a developer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals. NPM is a biopharmaceutical business that develops miniaturized subdermal drug implants using its NanoPortal technology for delivery of medicines to treat chronic diseases.

In connection with the merger, Second Sight changed its name to Vivani Medical Inc. The company’s common stock will trade on the Nasdaq Capital Market under the symbol “VANI.”

Upon completion of the merger, Vivani has approximately $55 million in cash to advance the development of its portfolio. It’s seeking to move lead asset NPM-119 (exenatide implant) into clinical-stage development for the treatment of patients with Type 2 diabetes and to advance its clinical-stage Orion visual prosthetic device to treat individuals with blindness.


Turn Patients Into Loyal Eyewear Shoppers

80% of patients are browsing eyewear online, are you influencing patients online before your competition? Join thousands of practices thriving with Optify, voted the #1 optical sales tool by EyeVote. Empower your opticians to save time, increase optical revenue, and maximize your EHR data and website with a seamless optical plug-in that keeps patients buying from YOU! Now through August 31st receive a $25 UberEats® gift card when you complete a 15 min demo. Book your demo here..

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular